Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate*
暂无分享,去创建一个
O. Fromigué | P. Marie | E. Haÿ | Olivia Fromigué | Pierre J Marie | Eric Haÿ | Alain Barbara | A. Barbara
[1] O. Fromigué,et al. Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelate , 2009 .
[2] H. Takayanagi. The Role of NFAT in Osteoclast Formation , 2007, Annals of the New York Academy of Sciences.
[3] E. Canalis,et al. Connective Tissue Growth Factor Enhances Osteoblastogenesis in Vitro* , 2008, Journal of Biological Chemistry.
[4] P. Marie,et al. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. , 1996, Bone.
[5] T. Spector,et al. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004, The New England journal of medicine.
[6] L. Topol,et al. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation , 2003, Development.
[7] H. Abboud,et al. Involvement of Calcineurin in Transforming Growth Factor-β-mediated Regulation of Extracellular Matrix Accumulation* , 2004, Journal of Biological Chemistry.
[8] B. Komm,et al. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. , 2007, Molecular endocrinology.
[9] Yoshiaki Kawano,et al. Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.
[10] K. Hankenson,et al. Wnt11 Promotes Osteoblast Maturation and Mineralization through R-spondin 2* , 2009, Journal of Biological Chemistry.
[11] F. Saltel,et al. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. , 2008, Bone.
[12] P. Marie. Strontium as therapy for osteoporosis. , 2005, Current opinion in pharmacology.
[13] Hiroshi Takayanagi,et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.
[14] P. Marie,et al. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. , 2004, Metabolism: clinical and experimental.
[15] E. Brown,et al. Extracellular calcium sensing and extracellular calcium signaling. , 2001, Physiological reviews.
[16] Oscar L. Sierra,et al. Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling* , 2008, Journal of Biological Chemistry.
[17] J. Woo,et al. The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells* , 2004, Journal of Biological Chemistry.
[18] Jianping Jin,et al. Dissection of sets of genes that control the character of wnt5a-deficient mouse calvarial cells. , 2008, Bone.
[19] R. Baron,et al. Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway* , 2005, Journal of Biological Chemistry.
[20] Michael C. Ostrowski,et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. , 2008, The Journal of clinical investigation.
[21] T. Yoneda,et al. Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity1 , 2006, The Journal of Immunology.
[22] Christof Niehrs,et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling , 2002, Nature.
[23] J. Molkentin,et al. The DnaJ-Related Factor Mrj Interacts with Nuclear Factor of Activated T Cells c3 and Mediates Transcriptional Repression through Class II Histone Deacetylase Recruitment , 2005, Molecular and Cellular Biology.
[24] Christopher R. Jacobs,et al. Non-Canonical Wnt Signaling and N-Cadherin Related β-Catenin Signaling Play a Role in Mechanically Induced Osteogenic Cell Fate , 2009, PloS one.
[25] T. Kodama,et al. NFAT and Osterix cooperatively regulate bone formation , 2005, Nature Medicine.
[26] H. Genant,et al. Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] R. Nusse,et al. Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context , 2006, PLoS biology.
[28] G. Boland,et al. Cross‐talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation , 2007, Journal of cellular biochemistry.
[29] G. Crabtree,et al. NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.
[30] M. Ruat,et al. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. , 2004, Biochemical and biophysical research communications.
[31] P. Marie,et al. S12911-2 reduces bone loss induced by short-term immobilization in rats. , 2003, Bone.
[32] E. Brown,et al. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. , 2007, Biochemical pharmacology.
[33] Monte M Winslow,et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. , 2006, Developmental cell.
[34] Ling-Ling Zhu,et al. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. , 2007, Biochemical and biophysical research communications.
[35] O. Blaschuk,et al. Calreticulin Affects β-Catenin-associated Pathways* , 2001, The Journal of Biological Chemistry.
[36] A. Matsuda,et al. PIASxβ is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts , 2007, Journal of Cell Science.
[37] Christopher C. Goodnow,et al. Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.
[38] B. L. Riggs,et al. Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] M. Katoh,et al. WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.
[40] T. Clemens,et al. Conditional Disruption of Calcineurin B1 in Osteoblasts Increases Bone Formation and Reduces Bone Resorption* , 2007, Journal of Biological Chemistry.
[41] M. Zayzafoon. Calcium/calmodulin signaling controls osteoblast growth and differentiation , 2006, Journal of cellular biochemistry.
[42] J. Reginster,et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. , 2005, The Journal of clinical endocrinology and metabolism.
[43] Li Sun,et al. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. , 2007, American journal of physiology. Renal physiology.
[44] J. McDonald,et al. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. , 2007, Bone.
[45] Chenbei Chang,et al. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. , 2008, Genes & development.
[46] P. Halbout,et al. Strontium Ranelate Promotes Osteoblastic Differentiation and Mineralization of Murine Bone Marrow Stromal Cells: Involvement of Prostaglandins , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[47] René Rizzoli,et al. Strontium Ranelate Treatment Improves Trabecular and Cortical Intrinsic Bone Tissue Quality, a Determinant of Bone Strength , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] Randall T. Moon,et al. Proximal events in Wnt signal transduction , 2009, Nature Reviews Molecular Cell Biology.
[49] Lin Chen,et al. Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.
[50] L. Raisz. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.
[51] Y. Gwack,et al. Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. , 2007, Cell calcium.
[52] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[53] R. Müller,et al. N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/β-Catenin Signaling, Osteoblast Function, and Bone Formation , 2008, Molecular and Cellular Biology.
[54] Tak W. Mak,et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis , 2005, The Journal of experimental medicine.
[55] Caiying Guo,et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation , 2005, Nature Genetics.